{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:57:37Z","timestamp":1788274657254,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.carrev.2012.10.003","type":"journal-article","created":{"date-parts":[[2012,11,16]],"date-time":"2012-11-16T23:04:23Z","timestamp":1353107063000},"page":"311-315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Clinical presentation and predictors of target vessel revascularization after drug-eluting stent implantation"],"prefix":"10.1016","volume":"13","author":[{"given":"Hazem","family":"Al Muradi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Okolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Vlachos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith","family":"Selzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar C.","family":"Marroquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Skelding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Holper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David O.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Dawn","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.carrev.2012.10.003_bb0005","first-page":"176","article-title":"Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial","volume":"4","author":"Brilakis","year":"2011","journal-title":"JACC: Cardiovasc Interven"},{"issue":"11","key":"10.1016\/j.carrev.2012.10.003_bb0010","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1001\/jama.295.11.1264","article-title":"Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial","volume":"295","author":"Holmes","year":"2006","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.carrev.2012.10.003_bb0015","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/CIRCULATIONAHA.105.562421","article-title":"Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial","volume":"112","author":"Sabate","year":"2005","journal-title":"Circulation"},{"issue":"9390","key":"10.1016\/j.carrev.2012.10.003_bb0020","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(03)14462-5","article-title":"Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS)","volume":"362","author":"Schofer","year":"2003","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.carrev.2012.10.003_bb0025","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/CIRCULATIONAHA.106.613588","article-title":"Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions","volume":"114","author":"Suttorp","year":"2006","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.carrev.2012.10.003_bb0030","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1161\/CIRCULATIONAHA.108.826479","article-title":"Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies","volume":"119","author":"Kirtane","year":"2009","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.carrev.2012.10.003_bb0035","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1161\/CIRCULATIONAHA.105.601823","article-title":"Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents","volume":"113","author":"Kastrati","year":"2006","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.carrev.2012.10.003_bb0040","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCINTERVENTIONS.110.946939","article-title":"Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry","volume":"3","author":"Stolker","year":"2010","journal-title":"Circ Cardiovasc Interven"},{"issue":"24","key":"10.1016\/j.carrev.2012.10.003_bb0045","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1161\/01.CIR.102.24.2945","article-title":"Percutaneous coronary intervention in the current era compared with 1985\u20131986: the National Heart, Lung, and Blood Institute Registries","volume":"102","author":"Williams","year":"2000","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.carrev.2012.10.003_bb0050","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.ahj.2005.08.011","article-title":"Bare metal stent restenosis is not a benign clinical entity","volume":"151","author":"Chen","year":"2006","journal-title":"Am Heart J"},{"issue":"21","key":"10.1016\/j.carrev.2012.10.003_bb0055","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.jacc.2007.07.071","article-title":"Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice: findings from the National Heart, Lung, and Blood Institute Dynamic Registry","volume":"50","author":"Abbott","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.carrev.2012.10.003_bb0060","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jcin.2009.03.013","article-title":"Impact of target lesion and nontarget lesion cardiac events on 5-year clinical outcomes after sirolimus-eluting or bare-metal stenting","volume":"2","author":"Chacko","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.carrev.2012.10.003_bb0065","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jacc.2011.11.024","article-title":"Coronary artery disease progression late after successful stent implantation","volume":"59","author":"Zellweger","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.carrev.2012.10.003_bb0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/01.CIR.0000150335.01285.12","article-title":"Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention","volume":"111","author":"Glaser","year":"2005","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.carrev.2012.10.003_bb0075","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1161\/01.CIR.0000121358.26097.06","article-title":"Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study","volume":"109","author":"Lemos","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.carrev.2012.10.003_bb0080","doi-asserted-by":"crossref","first-page":"159e4","DOI":"10.1016\/j.ahj.2009.11.021","article-title":"Effectiveness and safety of drug-eluting stents in vein grafts: a meta-analysis","volume":"159","author":"Joyal","year":"2010","journal-title":"Am Heart J"},{"issue":"17","key":"10.1016\/j.carrev.2012.10.003_bb0085","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.carrev.2012.10.003_bb0090","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1161\/01.CIR.0000131898.18849.65","article-title":"Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: insights from the Prevention of Restenosis With Tranilast and Its Outcomes (PRESTO) trial","volume":"109","author":"Singh","year":"2004","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.carrev.2012.10.003_bb0095","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0735-1097(97)00334-3","article-title":"Predictive factors of restenosis after coronary stent placement","volume":"30","author":"Kastrati","year":"1997","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.carrev.2012.10.003_bb0100","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0735-1097(02)02597-4","article-title":"Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials","volume":"40","author":"Cutlip","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.carrev.2012.10.003_bb0105","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/eurheartj\/ehi721","article-title":"Intracoronary Drug-Eluting Stenting to Abrogate Restenosis in Small Arteries Study I. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels","volume":"27","author":"Mehilli","year":"2006","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.carrev.2012.10.003_bb0110","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/CIRCULATIONAHA.106.667915","article-title":"Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry","volume":"114","author":"Williams","year":"2006","journal-title":"Circulation"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838912002333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838912002333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:08:17Z","timestamp":1761559697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838912002333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S1553838912002333"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2012.10.003","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical presentation and predictors of target vessel revascularization after drug-eluting stent implantation","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2012.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}